FDA hits Natco with warning letter over India facility, suspends product shipments to US
Manufacturer Natco Pharma was hit with a warning letter earlier this month over violations at its facility in the Indian state of Telangana, following an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.